COLUMBIA, Md.--(BUSINESS WIRE)--Igene Biotechnology, Inc., Columbia, Maryland (OTC:IGNE - news) announced today that its Board of Directors has concluded a stock purchase agreement of its exclusive sales agent ProBio Nutraceuticals A.S., Tromso, Norway, a privately held concern. The purchase of ProBio Nutraceuticals will provide the Company with a portfolio of dietary supplements products, additional management resources as well as an experienced marketing and sales force. Igene's goal is to achieve a meaningful share of the total $250 million world market for astaxanthin as pigment for farmed salmon and trout.